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Introduction: To the best of our knowledge, this is the first report of a case of conjunctival sarcoidosis that
presented as limbal conjunctival hypertrophy and was controlled with topical cyclosporine.
Case presentation: A 70-year-old Asian woman presented with painless limbal conjunctival hypertrophy. An
incisional biopsy of the hypertrophic lesion showed noncaseating granulomas that consisted of multinucleated
giant cells and epithelioid cells. The results of a systemic evaluation were normal except for a slight increase in
serum angiotensin-converting enzyme to 58.9IU/L (normal range, 8 to 55IU/L). Twice-daily 0.05% topical cyclosporine was
prescribed for the treatment of remaining lesions. After two months, the lesions had completely resolved and her serum
angiotensin-converting enzyme level had normalized.
Conclusions: Sarcoidosis should be considered in the differential diagnosis of conjunctival hypertrophy. Topical
cyclosporine can be useful in conjunctival sarcoidosis.
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Sarcoidosis is a multisystemic inflammatory process
characterized by noncaseating granulomatous infiltration
[1]. Ocular involvement is found in 20% to 50% of
patients; the most common complaint (30% to 70%) is
uveitis caused by an accumulation of T cells and mono-
nuclear cells [1,2]. Conjunctival involvement is also
frequently encountered (40%) and usually manifests as
conjunctival nodules associated with the formation of
noncaseating granulomas [1-3]. Although corticoste-
roids have been the mainstay of treatment in ocular
sarcoidosis, chronic use is frequently associated with
various side effects [3]. Thus, steroid-sparing agents,
including minocycline and cyclosporine, have been in-
troduced for the treatment of ocular sarcoidosis [2-4].
We present the case of a patient with isolated conjunc-
tival sarcoidosis presenting as limbal conjunctival hyper-
trophy who was successfully treated with 0.05% topical
cyclosporine.* Correspondence: jyhyon@snu.ac.kr
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A 70-year-old Asian woman was referred to our hospital
for an evaluation of limbal conjunctival hypertrophy
in her left eye. She reported mild discomfort but had
no other symptoms, such as pain or itching. She had
chronic angle closure glaucoma in her left eye and was
on 0.1% brimonidine twice a day and 0.005% latanoprost
four times a day. Her past medical history was unre-
markable except for hypertension and hyperlipidemia. A
slit-lamp examination showed multiple yellowish con-
junctival nodules in both eyes and hypertrophy around
the superior limbal area in her left eye (Figure 1A,B). An
incisional biopsy of the superior conjunctival tissue re-
vealed noncaseating granulomas that consisted of multi-
nucleated giant cells and epithelioid cells (Figure 1C).
No evidence of fungi, acid-fast bacilli or foreign bodies
was found. A systemic evaluation, including a physical
examination, chest X-ray and high-resolution computed
tomography, pulmonary function tests, and an analysis
of serum angiotensin-converting enzyme (ACE), anti-
neutrophil cytoplasmic antibody, and serum and urinary
calcium were performed. All results were normal except
a mildly increased serum ACE level of 58.9IU/L (normal
range, 8 to 55IU/L). She was prescribed 0.05% topical cyclo-
sporine twice daily for the treatment of the remaining. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Anterior segment photography and histologic examination at presentation. (A) Anterior segment photography of the left eye at
presentation. Yellowish conjunctival hypertrophy around the limbus is observed. (B) Anterior segment photography of the right eye at
presentation. Multiple yellowish conjunctival nodules are observed. (C) Histological examination shows noncaseating granulomas that consist of
multinucleated giant cells and epithelioid macrophages (black arrows) in the conjunctival stroma (hematoxylin and eosin staining, original
magnification × 200).
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completely resolved (Figure 2), and her serum ACE level
had normalized to 44.1IU/L. The topical cyclosporine was
discontinued.
Discussion
Although conjunctival sarcoidosis mostly presents as mul-
tiple nodules resembling follicular conjunctivitis, other con-
junctival manifestations including conjunctival deposit,
large conjunctival tumor and multilobular limbal nodules
have been reported [1-3,5-7]. The differential diagnosis of
limbal hypertrophy includes vernal keratoconjunctivitis,
atopic keratoconjunctivitis, allergic conjunctivitis, superior
limbic keratoconjunctivitis, trachoma, ligneous conjunc-
tivitis, soft contact lens complication, and conjunctival tu-
mors such as papilloma, lymphoma and intraepithelial
neoplasia [8,9]. However, sarcoidosis has rarely been con-
sidered in the differential diagnosis, and in fact, our pa-
tient was referred to us with an impression of conjunctival
neoplasia. In most cases of conjunctival sarcoidosis,
the granulomatous inflammation results in conjunctival
nodules. However, in our patient, there was a large
amount of granulomatous infiltration around the super-
ior perilimbal area, and it may have led to the limbal
conjunctival hypertrophy.Figure 2 Anterior segment photography after treatment. (A) Anterior s
cyclosporine. Complete resolution of conjunctival nodules is observed. (B) Ante
topical cyclosporine. Resolution of the limbal conjunctival hypertrophy is observ
incisional biopsy.Cyclosporine is known to be useful in various ocular
surface inflammatory diseases, such as ocular rosacea,
dry eye disease, atopic keratoconjunctivitis, graft-versus-
host disease and herpetic stromal keratitis, due to its
anti-inflammatory and immunomodulatory action [10].
Although the pathogenesis of sarcoidosis is still unclear,
cluster of differentiation (CD) 4 T cells appear to play
an important role in granuloma formation [1,2]. Ac-
cordingly, cyclosporine is expected to be useful for its
selective inhibitory effect on CD4+ T lymphocyte prolif-
eration via inhibition of interleukin-2 receptor expres-
sion [1,3]. Oral cyclosporine is shown to be effective in
vision-threatening ocular sarcoidosis as well as refrac-
tory systemic sarcoidosis [3]. Topical cyclosporine was
also effective in the treatment of conjunctival sarcoidosis in
steroid-responders [2,3]. We also chose topical cyclosporine
instead of steroids due to pre-existing glaucoma in our pa-
tient. Unlike previous cases [2,3], our patient’s serum ACE
level was elevated, and normalized in response to the cyclo-
sporine treatment. In patients with sarcoidosis, serum ACE
levels are elevated due to marked synthesis by epithelioid
cells, thus the ACE level reflects the mass of ACE-
producing granuloma cells [11]. Therefore, although an
elevated serum ACE level is not a specific finding for sar-
coidosis, serial measurements of serum ACE level are usefulegment photography of the right eye taken after treatment with topical
rior segment photography of the left eye taken after treatment with
ed. The superior part of the hypertrophic conjunctiva was removed with
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elevated ACE level normalized with the disappearance of
conjunctival lesions, which suggests suppression of disease
activity with the use of topical cyclosporine.
Conclusions
Our experience suggests that sarcoidosis can manifest as
limbal conjunctival hypertrophy, and should therefore be
included in the differential diagnosis of sarcoidosis. Topical
cyclosporine can be a useful option in the treatment of con-
junctival sarcoidosis, especially when there are concerns
about steroid side effects.
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